Numerous studies demonstrated the dysregulation of Nrf2/Keap1/ARE pathways in many chronic diseases, including diabetes mellitus, obesity, and atherosclerosis (Cuadrado et al., 2019; da Costa et al., 2019). Here, NFE2L2 is linked to obesity due to melanocortin 4 receptor deficiency.